Clinical trial
Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease
NCT05971329 is registered in ClinicalTrials.gov with Zetagen Therapeutics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease
- Lead sponsor
- Zetagen Therapeutics, Inc
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 30, 2026
- Completion date
- September 30, 2027
- Enrollment
- 10 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
disc degeneration, disc disease, myelopathy cervical, neurological abnormality, radiculopathy, cervical